Physicochemical Properties
| Molecular Formula | C16H29NAO2 |
| Molecular Weight | 276.390036344528 |
| Exact Mass | 276.206 |
| CAS # | 217477-25-3 |
| Related CAS # | Sapienic acid;17004-51-2 |
| PubChem CID | 146014461 |
| Appearance | Off-white to light yellow ointment |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 13 |
| Heavy Atom Count | 19 |
| Complexity | 215 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CCCCCCCCC/C=C\CCCCC(=O)[O-].[Na+] |
| InChi Key | MTXLIDQLSMYYRU-GMFCBQQYSA-M |
| InChi Code | InChI=1S/C16H30O2.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18;/h10-11H,2-9,12-15H2,1H3,(H,17,18);/q;+1/p-1/b11-10-; |
| Chemical Name | sodium;(Z)-hexadec-6-enoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Sapienic acid is active against Streptococcus sanguinis, Streptococcus mitis, and Fusobacterium nucleatum; however, it is inactive against Salmonella marcescens, Pseudomonas aeruginosa, Escherichia coli, Corynebacterium bovis inactive, Corynebacterium striatum, and Corynebacterium jeckii (with a minimum bactericidal concentration (MBC) of 31.3 to 375.0 μg/mL). According to kinetic studies, sapienic acid gradually kills Streptococcus sanguinis and Streptococcus mitis over the course of 24 hours [1]. |
| References |
[1]. Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother. 2012 Mar;56(3):1157-61. |
Solubility Data
| Solubility (In Vitro) | Ethanol : ~33.33 mg/mL (~120.59 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% EtOH + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% EtOH + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.05 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.6181 mL | 18.0904 mL | 36.1808 mL | |
| 5 mM | 0.7236 mL | 3.6181 mL | 7.2362 mL | |
| 10 mM | 0.3618 mL | 1.8090 mL | 3.6181 mL |